Filter
2650
Text search:
TB
drugs
Featured
Recommendations
240
New Publications
804
Language
Document type
No document type
1836
Guidelines
290
Studies & Reports
285
Manuals
76
Strategic & Response Plan
70
Training Material
33
Fact sheets
32
Situation Updates
13
Infographics
8
Resource Platforms
5
Brochures
1
Online Courses
1
Countries / Regions
India
183
Kenya
104
South Africa
92
Ethiopia
67
Western and Central Europe
65
Zambia
64
Tanzania
63
Uganda
62
Nepal
59
Global
59
Nigeria
56
Malawi
53
Sierra Leone
48
Rwanda
44
Liberia
43
Eastern Europe
43
Africa
39
Bangladesh
37
Namibia
37
Ghana
35
Myanmar / Burma
34
Ukraine
33
Lesotho
33
Philippines
29
Asia
28
Cambodia
26
Indonesia
24
Zimbabwe
23
Latin America and the Carribbean
21
Botswana
20
South–East Asia Region
20
Russia
14
Senegal
13
Mozambique
13
Eswatini/ Swaziland
12
Colombia
12
Burkina Faso
11
Congo, Democratic Republic of
10
Pakistan
10
Benin
9
Argentina
8
Peru
8
East and Southern Africa
8
Albania
7
Haiti
6
South Sudan
6
Germany
6
Syria
6
Tajikistan
6
Georgia
6
Cameroon
5
Thailand
5
Brazil
5
Afghanistan
4
Bolivia
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Venezuela
4
Armenia
4
Southern Africa
4
Guinea
3
Somalia
3
Jordan
3
Lebanon
3
Sudan
3
Sri Lanka
3
Middle East and North Africa
3
Western Pacific Region
3
Paraguay
3
Bhutan
3
Laos
3
Estonia
3
Moldova
3
Iran
3
Vietnam
3
Saudi Arabia
2
Iraq
2
Papua New Guinea
2
North Macedonia
2
Burundi
2
Ecuador
2
El Salvador
2
Yemen
2
Poland
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Uruguay
2
Mali
1
Morocco
1
USA
1
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Central African Republic
1
Hungary
1
Honduras
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1248
Clinical Guidelines
213
Public Health
79
Women & Child Health
70
Key Resources
54
Capacity Building
36
Pharmacy & Technologies
24
Annual Report MEDBOX
1
Toolboxes
TB
517
HIV
445
AMR
100
Pharmacy
59
NTDs
52
COVID-19
47
Mental Health
45
Caregiver
44
Refugee
29
Health Financing Toolbox
26
NCDs
24
Global Health Education
21
Ebola & Marburg
20
Conflict
19
Polio
18
Disability
15
Natural Hazards
11
Malaria
11
Rapid Response
9
Planetary Health
9
Social Ethics
5
Specific Hazards
3
2.0 Rapid Response
3
Cholera
1
South Sudan
1
Zika
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
TB treatment for children is fundamentally the same as for adults, with a combination of TB drugs needing to be taken for a number of months.
...
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных нарко
...
Key populations brief.
Key populations brief.
Краткое руководство
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the disease and both subspecies of the parasite, T.b. g
...
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and
...
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key inte
...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Therapy for MDR-TB is extremely long, complex and burdensome to both patients and health care systems. A single diagnosis can require two years of treatment, or longer. When treating children, there are significant additional barriers treating child
...
Accessed 2017
Please Download all Documents directly from the website: https://www.finddx.org/tb-laboratory-standard-operating-procedures-sops/
Laboratory Quality (TB01), General Procedures (TB02), Specimen Handling (TB03), Microscopy Procedures
...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- an
...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatmen
...
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed
...
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have b
...